4.3 Article

The Role of Aneuploidy in Cancer Evolution

期刊

出版社

COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT
DOI: 10.1101/cshperspect.a028373

关键词

-

资金

  1. Novo Nordisk Foundation [16584]
  2. Canadian Institutes of Health Research (CIHR)
  3. European Molecular Biology Organization (EMBO)
  4. Cancer Research UK (TRACERx)
  5. Royal Society
  6. CRUK Lung Cancer Centre of Excellence
  7. Stand Up 2 Cancer (SU2C)
  8. Rose-trees Trust
  9. EU [259303]
  10. Prostate Cancer Foundation
  11. Breast Cancer Research Foundation
  12. European Research Council (THESEUS)
  13. National Institute for Health Research/University College London Hospitals Biomedical Research Centre
  14. Novo Nordisk Fonden [NNF15OC0016584] Funding Source: researchfish

向作者/读者索取更多资源

Chromosomal aberrations during cell division represent one of the first recognized features of human cancer cells, and modern detection methods have revealed the pervasiveness of aneuploidy in cancer. The ongoing karyotypic changes brought about by chromosomal instability (CIN) contribute to tumor heterogeneity, drug resistance, and treatment failure. Whole-chromosome and segmental aneuploidies resulting from CIN have been proposed to allow macroevolutionary leaps that may contribute to profound phenotypic change. In this review, we will outline evidence indicating that aneuploidy and CIN contribute to cancer evolution.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据